The evaluation, led by Dr. William Dixon, tracked 61 consecutive procedures, including coronary angiography and percutaneous coronary interventions. Rather than focusing solely on percentage reductions, the study established clinical benchmarks for occupational dose, recording an average normalized exposure of 0.83 mrem for primary operators and 0.09 mrem for sedation nurses. Beyond safety metrics, the report highlights the device's practical utility, noting 100% procedural utilization and minimal disruption to room turnover or patient access.
Dan Lormon, VP of Medical Affairs at Salus Scientific, argues that meaningful adoption of protection technology requires more than just shielding capability; it demands seamless integration into the high-pressure environment of the cath lab. Dr. Dixon echoed this sentiment, noting that the team achieved proficiency within two cases, allowing clinicians to focus entirely on patient care rather than the equipment. This publication marks the start of a broader multicenter program intended to standardize how hospitals evaluate safety tools in procedural medicine.

Comments (0)
No comments yet. Be the first!